Dr. Said Daneshmand is an internationally recognized Fertility specialist with extensive experience in complex IVF cases, as well as Egg Donor/Surrogacy Third party care.
Dr. Daneshmand serves on the board of several Surrogacy Advocacy groups. He has collaborated to develop in vitro fertilization (IVF) protocols to improve pregnancy rates, including PTEC (post-thaw extended culture), which was one of the most successful IVF regimens that led to a surge in Frozen embryo transfers, as a means to maximize endometrial receptivity. These groundbreaking findings have been published in the internationally respected medical journal, Fertility and Sterility, where Dr. Daneshmand also served as a reviewer.
Dr. Daneshmand completed his fellowship and residency at UCLA. He is specialty board certified in Obstetrics and Gynecology and sub-specialty board certified in Reproductive Endocrinology.
He is the recipient of numerous awards including the Eileen Pike Medical School Valedictorian Award, the PCRS Fellowship and Practicing Physician Research Award, and the ASRM STAR AWARD, awarded to a select group of research scientists who have presented their original research at the American Society of Reproductive Medicine Conference for 10+ consecutive years. He has served as the President of the Alpha Omega Alpha Honor Society (Iota Chapter) and is a member of the DeCherney Society, the American Society for Reproductive Medicine (ASRM) and the European Society of Human Reproduction and Embryology (ESHRE). Dr. Daneshmand speaks French, Spanish and Farsi.
Intended parents have travelled from more than 40 countries in 2019 alone to seek his help in their journey to parenthood. He was the Principal Investigator in the Multi-Center Global research trial of non-invasive PGT-A, the latest technique for assessing embryonic genetic health without the need for embryo biopsy.